The Differences in INA-CBG's Claims and Direct Medical Costs for Inpatient Breast Cancer in Class A and B Hospital IN PRESS

Diesty Anita Nugraheni (1) , Fanyda Amiyassin Hafi'ah (2) , May Syahra Indah Permata Harlin (3) , Aji Tetuko (4)
(1) Prodi Farmasi Universitas Islam Indonesia , Indonesia
(2) Prodi Farmasi Universitas Islam Indonesia , Indonesia
(3) Prodi Farmasi Universitas Islam Indonesia , Indonesia
(4) Prodi Farmasi Stikes AKBIDYO Yogyakarta , Indonesia

Abstract

With a total cost of 3.5 trillion rupiahs, cancer ranks second due to its high price and potential for life-threatening complications. The purpose of this study is to ascertain whether real costs in Indonesian Hospital Types A and B that use INA-CBG rates for JKN patients are appropriate given INA-CBG code C-3-13-0. Methods: A cross-sectional research approach was used in this observational study. By looking up medication information, cost information, and medical record documents for outpatient cancer patients at Type A and B hospitals for 2021, data was obtained retroactively. The Mann-Whitney test was employed in statistical analysis to determine the discrepancy between INA-CBG's rates and actual expenditures. Findings: PBI outpatient breast cancer patients at Type A Hospital had average direct medical costs of IDR 3,397,073, non-PBI patients IDR 3,439,253, and medical cost components IDR 2,619,355.26 at Type B Hospital. Drug bills are the largest direct contributor. The true costs in Type A hospitals for PBI patients are less than Rp 88,041,600; for non-PBI patients, the difference is minus Rp 91,386,300; and for patients in Type B hospitals, the difference is minus Rp 164,113,635. Conclusion: For patients with outpatient breast cancer at Type A and B hospitals, there is a considerable discrepancy between the true expenses and the total INA-CBG rates (p = 0.0001).  

Full text article

Generated from XML file

Authors

Diesty Anita Nugraheni
diesty.anita@uii.ac.id (Primary Contact)
Fanyda Amiyassin Hafi'ah
May Syahra Indah Permata Harlin
Aji Tetuko
1.
Nugraheni DA, Hafi’ah FA, Harlin MSIP, Tetuko A. The Differences in INA-CBG’s Claims and Direct Medical Costs for Inpatient Breast Cancer in Class A and B Hospital: IN PRESS. JIKM [Internet]. 2024 Aug. 20 [cited 2024 Sep. 17];15(2). Available from: https://ejournal.fkm.unsri.ac.id/index.php/jikm/article/view/1601

Article Details